Old Mission Capital’s Gilead Sciences GILD Stock Holding History

Old Mission Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,267	Closed	-$448K	–	1551
2022 Q3	$448K	Buy	+7,267	New	+$458K	0.01%	603
2022 Q1	–	Sell	-37,003	Closed	-$2.69M	–	1457
2021 Q4	$2.69M	Buy	+37,003	New	+$2.55M	0.11%	186
2018 Q1	–	Sell	-6,151	Closed	-$441K	–	433
2017 Q4	$441K	Buy	+6,151	New	+$467K	0.03%	256

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Old Mission Capital's GILD Position: Q4 2022 in Review

Old Mission Capital sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 7,267 shares — an estimated $448K sold.

Old Mission Capital first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $2.69M in Q4 2021. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Old Mission Capital reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
Old Mission Capital sold 7,267 Gilead Sciences shares in Q4 2022, an estimated $448K.
Old Mission Capital first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
Old Mission Capital's Gilead Sciences position peaked at $2.69M in Q4 2021.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Old Mission Capital's 13F filing for Q4 2022, filed 14 Feb 2023.